Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
ESC Heart Failure|November 24, 2020
Time-weighted lactate as a predictor of adverse outcome in acute heart failureGiorgio Bosso, Valentina Mercurio, Nermin Diab, et al.BMJ Open Quality|December 1, 2022
Development and assessment of an educational intervention to improve the recognition of frailty on an acute care respiratory wardAaron Leblanc, Nermin Diab, Chantal Backman, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 12, 2026
Protocol for a multinational, investigator-initiated, parallel group, randomised, double-blind, placebo-controlled phase 3b superiority trial assessing the effect of dupilumab on inducing clinical remission outcomes in at-risk type-2 inflammatory asthma (HOTHOT)Simon Couillard, Nayia Petousi, Sanjay Ramakrishnan, et al.Pulmonary Circulation|March 27, 2018
Pulmonary arterial hypertension and atrial arrhythmias: incidence, risk factors, and clinical impactValentina Mercurio, Grace Peloquin, Khalil I Bourji, et al.Lung|July 15, 2026
FeNO as a Treatable Trait in Chronic Cough: Insights from the PROCOUGH StudyMustafaa Wahab, Elena Kum, Nermin Diab, et al.Chest|May 15, 2026
Moving Beyond Responders: A post-hoc Analysis Identifying Criteria for Chronic Cough ControlMustafaa Wahab, Elena Kum, Nermin Diab, et al.Lung|February 22, 2023
Canadian Health Care Professionals' Familiarity with Chronic Cough Guidelines and Experiences with Diagnosis and Management: A Cross-Sectional SurveyElena Kum, Danica Brister, Nermin Diab, et al.The European Respiratory Journal|November 6, 2025
Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomized, double-blind, parallel-group, placebo-controlled trialNermin Diab, Danica Brister, Elena Kum, et al.ERJ Open Research|May 19, 2022
Causes and outcomes of ICU hospitalisations in patients with pulmonary arterial hypertensionMario Naranjo, Valentina Mercurio, Hussein Hassan, et al.Nature Communications|July 2, 2025
Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trialMangalakumari Jeyanathan, Sam Afkhami, Michael R D'Agostino, et al.Pageof 2